Pioneering Science for Patient Choice

Advancing new oral alternatives for all people living with hereditary angioedema (HAE)

Pharvaris text logo

Pharvaris is committed to improving the treatment of HAE and the quality of life for people living with HAE through our innovative research, discovery, development, and manufacturing of novel therapeutics

learn about our clinical trials

oral on-demand treatment study

extension study of oral on-demand treatment

oral prophylactic treatment study

We aim to treat all clinical signs of HAE attacks and prevent the occurrence of attacks

Our Scientific Approach:
Bradykinin B2 Receptor antagonists

Our Pipeline:
Orally available small molecules